Guangdong Taienkang Pharmaceutical Co. Ltd (301263) — Financial Flexibility Index
Guangdong Taienkang Pharmaceutical Co. Ltd (301263) has a Financial Flexibility Index of 0.14x as of December 2025. Free cash flow of CN¥95.40 Million (operating CF CN¥-12.88 Million minus capex CN¥108.28 Million) represents 0% of total liabilities (CN¥676.07 Million). Also explore 301263 net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Guangdong Taienkang Pharmaceutical Co. Ltd Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Guangdong Taienkang Pharmaceutical Co. Ltd across 7 annual periods. Check 301263 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Guangdong Taienkang Pharmaceutical Co. Ltd (2019–2025)
Year-by-year free cash flow to debt coverage for Guangdong Taienkang Pharmaceutical Co. Ltd. For the full company profile including market capitalisation, see Guangdong Taienkang Pharmaceutical Co. L stock valuation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.14x | CN¥95.40 Million | CN¥-12.88 Million | CN¥676.07 Million | ▼ -55.8% |
| 2024 | 0.32x | CN¥157.88 Million | CN¥89.33 Million | CN¥494.67 Million | ▼ -56.5% |
| 2023 | 0.73x | CN¥293.53 Million | CN¥93.53 Million | CN¥399.72 Million | ▼ -42.9% |
| 2022 | 1.29x | CN¥238.69 Million | CN¥148.81 Million | CN¥185.63 Million | ▲ +80.9% |
| 2021 | 0.71x | CN¥164.67 Million | CN¥120.02 Million | CN¥231.71 Million | ▼ -20.3% |
| 2020 | 0.89x | CN¥218.65 Million | CN¥125.53 Million | CN¥245.12 Million | ▲ +91.7% |
| 2019 | 0.47x | CN¥84.27 Million | CN¥75.44 Million | CN¥181.16 Million | — |